Atlas Trials

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Clinical trial NCT04697576 · RECRUITING

Trial details

NCT number
NCT04697576
Sponsor
Carlo Contreras
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8Clinical Stage IB Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage IIA Cutaneous Melanoma AJCC v8Clinical Stage IIB Cutaneous Melanoma AJCC v8Clinical Stage IIC Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma
Start date
2021-10-20
Primary completion
2027-09-30
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.